Skin Analytics Employee Directory
Hospitals and Health CareEngland, United Kingdom51-200 Employees
Skin Analytics is a London-based health technology company that has developed DERM, an AI-powered medical device designed to support skin cancer assessment pathways for NHS organisations. Its pathways aim to discharge benign lesions earlier in the diagnostic process to reduce backlog and free up dermatology capacity for potentially life-saving skin cancer treatment, with deployment across 25 NHS primary and secondary care organisations since 2020. The firm also provides remote skin assessment services for insurers such as Bupa and Vitality, extending its reach beyond traditional NHS settings. In the NHS context, DERM is described as the first and only AI skin cancer pathway, is recommended by NICE, and is the only Class III CE-marked AI medical device for skin cancer. To date, pathways including DERM have served more than 170,000 NHS patients and identified over 15,500 cancers, contributing to substantial reductions in face-to-face secondary care appointments. The company operates within Hospitals and Health Care, and recent partnerships indicate expansion into international markets, such as a June 2026 collaboration with Healthdirect Australia to advance AI-enabled health screening capabilities.